Respirology

Article	Citations
P4‐13: Assessment of the impact of atmospheric air microsuspensions on the respiratory function of patients with chronic obstructive pulmonary disease	128
O5‐5: Current smoking by socioeconomic status in a representative Japanese population	114
P6‐17: Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis (MTB) identification in patients with pulmonary tuberculosis	93
P5‐109: A fatal case of multiple mycotic pulmonary artery aneurysms due to Aspergillus terreus in a post COVID‐19 patient	91
O18‐3: Analysis of nocturnal desaturation waveform by using algorithm in the patients with idiopathic pulmonary fibrosis	78
P7‐65: Correlation between body mass index (BMI) and chronic obstructive pulmonary disease (COPD)	77
P8‐177: Chest wall Ewing's sarcoma – A diagnostic and therapeutic adventure	74
P11‐14: Blood gas analysis and alveolar‐arterial gradient as predictor of mortality confirmed COVID‐19 patients outcome in Tertiary Referral Hospital	58
P5‐43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID‐19 pneumonia in pregnancy	53
P10‐12: Risk factors for poor sleep quality and excessive daytime sleepiness in late pregnancy: A preliminary analysis of a cross‐sectional survey	49
P1‐15: Chest X‐ray improvement in COVID‐19 moderate symptoms with remdesvir and favipiravir: A comparative study	47
P8‐26: Study of the number of courses required for the first response to immune checkpoint inhibitor (+chemo) therapy for lung cancer	44
P1‐66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report	44
O5‐4: The effects of smoking cessation therapy on pulmonary function and predictive factor of the FEV1 increase	43
O20‐1: Spinal cord infarction after bronchial artery embolization using coils for hemoptysis: A single‐center retrospective analysis of 3046 procedures	43
P16‐93: Preliminary analysis of serum risk factors during an acute exacerbation of chronic fibrosing interstitial pneumonia: A multi‐institutional prospective study	40
O18‐5: Sleep apnea and academic performance: A study on medical students using the Berlin questionnaire	40
P12‐21: The recommended image features of peripheral lung parenchymal targets for diagnosis by CT‐guided needle biopsy	36
P6‐36: Components system of nitric oxide as markers of pulmonary multi‐drug resistant tuberculosis process activity	36
P6‐28: Clinical case of using intravenous forms of anti‐tuberculosis drugs to improve the treatment efficiency of tuberculosis in patients with malabsorption syndrome (MS)	36
O3‐6: The Pulmonary Endothelium Plays a Critical Role in the Fibrotic Response to Lung Injury through S1PR1 and ROCK Mediated Cytoskeletal Rearrangements	36
P8‐83: Giant pleuro parenchymal metastases from a rare primary tumor	35
P1‐88: Persistent bilateral unprovoked pulmonary embolism ‐ A case of chronic thromboembolic pulmonary hypertension in a young lady with seronegative antiphospholipid syndrome	35
P9‐27: Clinical feature and effectiveness of benralizumab therapy for severe asthma	34
P5‐55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome?	33

	33
P11‐8: Surviving covid: A case report on the first covid survivor after extracorporeal membrane oxygenation (ECMO) in the Philippines	33
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	33
P9‐85: The reaction of the pituitary‐adrenal system to cold bronchoprovocation in asthma patients with subclinical hypothyroidism	33
Bayesian adaptive clinical trial designs for respiratory medicine	32
APSR 2024 Abstracts	30
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	29
Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk	28
Language concordance in healthcare: Beyond just talk	27
Proteomic and other ‘‐omic’ analyses to develop disease stage‐specific platforms and therapeutic strategies for COPD: It is about time	27
Omics technologies to study virus infection and chronic lung diseases	27
Prevention of droplet dispersal with ‘e‐mask’: A new daily use endoscopic mask during bronchoscopy	26
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study	26
Improving support of informal carers of respiratory patients	26
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes	26
Decline in respiratory and cardiac admissions during the COVID‐19 pandemic: What is the role of common respiratory virus infections?	26
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	25
Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2	25
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	25
The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature	25
Response to “Fixed CPAP at 10 cmH2O for OSA: A One‐Size‐Fits‐All Approach?”	23
	21
Issue Information	21
	21
O8‐2: Clinical impact by phenotyping empyema based on pleural fluid culture positivity and appearance: A 7‐year retrospective analysis	20
O23‐1: Clinical features of novel phenotype in pulmonary hypertension along with mild lung parenchymal change without severe ventilatory impairment	20
P5‐155: Legionella pneumophilia pneumonia with rapid clinical course in a lung cancer patient	19
P7‐43: The impact of fungal sensitization on clinical features in asthma and chronic pulmonary obstructive disease	19
P2‐42: Effects of protease‐activated receptor antagonist on steroid insensitive airway inflammation induced by LPS in mice	18
P15‐3: Potential amelioration of pulmonary hypertension in COPD by budesonide/glycopyrronium/formoterol via central NFκB inflammatory signaling deactivation: In vivo mouse model	18
P6‐9: A post covid activation of latent tuberculosis	18
O9‐1: Urticaria—A Major systemic drug reaction under 1HP tuberculosis prevention in non‐HIV population	17
P12‐32: Cryo‐recanalization in a case of recurrent endobronchial diffuse large B‐cell lymphoma	17
P8‐18: Analysis of trace element concentrations and relationship between trace element and prognosis in lung cancer patients	17
P7‐49: Clinical experience of budesonide/glycopyrrolate/formoterol in patients with chronic obstructive pulmonary disease	17
P16‐86: Tolerability and safety of nintedanib for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung diseases	17
P5‐39: Impact of chronic co‐infection in pulmonary Mycobacterium avium complex disease after commencing treatment	17
P16‐71: Factors associated with pulmonary function decline in patients with rheumatoid arthritis‐associated interstitial lung disease	17
P16‐48: The prognostic marker of polymyxin B‐immobilized fiber column‐direct hemoperfusion in patients who developed acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia	16
O2‐2: Development and implementation of an aspiration pneumonia diagnostic algorithm for the practical application of the JRS guidelines	16
P16‐49: Analysis of lymphocyte fractions in bronchoalveolar lavage fluid in chronic eosinophilic pneumonia	16
P4‐23: A case report of bronchial anthracofibrosis – A Sri Lankan experience	16
P6‐43: Multicenter Prospective Study on Gouty Arthritis and Predictors of Outcomes among Filipino Patients on Anti‐Tuberculosis Treatment	16
P16‐96: Efficacy and safety of combination therapy of antifibrotic agents in patients with idiopathic pulmonary fibrosis	16
P1‐83: A case report of primi 30 weeks of pregnancy with COVID‐19 pneumonia with dengue fever	15
P2‐46: Effect of high fat diet on the severity and repair of lung fibrosis in mice	15
P9‐55: Inhaler techniques and confidence of use of inhalers	15
P1‐12: Eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome) presenting as acute polyneuropathy mimicking Guillain‐Barre syndrome ‐ A case report	15
	15
P12‐24: Tracheo‐ bronchial stenosis‐ different clinical presentations and individualised treatment approach	15

P6‐29: A case of elderly female with unresponsive anti‐tuberculosis therapy in rural area	15
Issue Information	14
The chicken or the egg: Sleep or physical activity?	14
Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure	14
A New Opportunity in Respirology	14
Obesity is a major contributing cause of breathlessness in the population	14
Singing in and out of COVID	14
Allele‐specific micro‐RNA‐mediated regulation of ADAM33 in childhood allergic asthma	14
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	14
From light to sound: Ultrasound outshines Light's criteria for pleural effusions classification	14
Stepping down for mild asthma and disadvantages of the ‘as‐needed’ strategy—Perspectives from a developing country	13
Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs	13
Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing	13
Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health	13
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?	13
Adding some NOVELTY to treatable traits	13
Associations of early life and childhood risk factors with obstructive sleep apnoea in middle‐age	13
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	12
Abstract	12
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis	12
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	12
P4‐24: Respiratory symptoms and lung function among active smokers in Indonesian college students	11
P8‐31: Prospective observational study of sequential afatinib and osimertinib in NSCLC patients with EGFR mutation: Gio‐Tag Japan	11
P16‐16: The role of statins on the risk of the cancer among the interstitial lung diseases and pulmonary fibrosis: A time‐dependent in propensity‐matched general population study focus on the immunolo	11
P9‐21: Inhaled corticosteroids for all asthma	11
O4‐2: Serum albumin in furry animals as a cross‐reactive component may cause more severe allergic symptoms	11
O1‐4: Prognosis of Japanese patients with late‐onset non‐infectious pulmonary complications after hematopoietic stem cell transplantation registered for lung transplantation	11
P16‐55: Additional effects of macrolides on steroid pulse therapy in patients with acute exacerbation of interstitial lung disease	11
P5‐48: Shrot versus long antibiotic course for pleural infection management: A randomised trial	11
P3‐13: IL‐17A acutely modulates airway smooth muscle contractility by PKC‐alpha‐mediated RhoA activation	11
P8‐50: Lung cancer, as a risk factor for abdominal aortic aneurysm (AAA)	11
P12‐36: Bronchoscopic cryo‐excision of a large chondroid hemartoma presented as right middle lobe collapse in a 63 yrs gentleman	11
P6‐22: Characteristics of pulmonary tuberculosis with delayed diagnosis in our hospital	10
P1‐94: The challenges of patients that with home using long term oxygen therapy under coronavirus pandemic	10
P7‐5: Sex‐specific differences of prevalence and risk factors for chronic obstructive pulmonary disease in subjects with preserved ratio impaired spirometry	10
P5‐89: Effectiveness of a questionnaire to screen COVID‐19	10
P8‐86: Puncture frequency is the determinants of iatrogenic pneumothorax in preoperative pulmonary nodule localization: A propensity matched study	10
P8‐4: An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma	10
P7‐29: Muscle mass evaluation using body composition analysis for COPD patients	10
P16‐50: Clinical features of pleuroparenchymal fibroelastosis: Idiopathic versus secondary phenotype	10
P9‐80: Exposures to cigarette smoke and house dust in relation to child asthma at Harum Melati Clinic, Pringsewu Regency, Lampung, Indonesia	10
P16‐34: Clinical investigation of the relationship between interstitial lung disease and obstructive sleep apnea	9
Letter from Vietnam	9
P9‐77: The correlation of childhood asthma and family history of atopy in Harum Melati clinic, Pringsewu, Lampung, INDONESIA	9
P5‐37: Community‐acquired respiratory virus cases mimic COVID‐19 on lung computed tomography	9
P16‐83: HRCT scoring focused on ground‐glass opacity, perilobular opacity, airspace consolidation, and interlobular septal thickening is useful for interstitial lung disease accompanied by anti‐MDA5 a	9
	9
Issue Information	9
Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD: Evidence from NHAN	9
Corrigendum	9
Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?	9
Issue Information	9
P5‐25: Spontaneous development of pneumocystis pneumonia in mice lacking death ligand‐induced apoptosis and necroptosis	8
P5‐151: Changes over time in six‐minute walk test and the SGRQ scores in patients with nontuberculous mycobacterial pulmonary disease	8
Thoracic Society of Australia and New Zealand (TSANZ) Is Abrogating Its Leadership Role in Asia‐Pacific	8
P3‐9: Allergy in IgG4‐related disease	8
P6‐65: A case of tuberculosis infection with a particular clinical course and difficulty in treatment	8
Abstracts	8
Issue Information	8
P5‐149: Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine	8
P5‐57: Comparison of chest HRCT findings between COVID‐19 pneumonia and anti‐MDA5 antibody‐positive interstitial pneumonia by computer‐based quantitative CT image analysis	8
Issue Information	8
	8
Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions	7
Author Index	7
Chest x‐ray has low sensitivity to detect silicosis in artificial stone benchtop industry workers	7
A snorkel mask with a 3D‐printed adaptor to HEPA filter was used in a COVID‐19 emergency ward to provide safe respiratory support	7
Sleep medicine is more than just obstructive sleep apnoea	7
The 63rd Annual Meeting of the Japanese Respiratory Society	7
The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes	7
My Lungs Have Feelings Too!	7
Pneumothorax in Endobronchial Valve Therapy–Still a Lot to Be Learned	7
	7
Severe asthma, more than that?	7
Uncontrolled mild‐to‐moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping	7
An additional mechanism enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula	7
Corrigendum	7
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	7
Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis	7
P7‐6: The association between alkaline phosphatase and COPD symptoms, severity, and exacerbation	7

Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers	7
Letter from Australia	7
Laryngeal hypersensitivity and abnormal cough response during mannitol bronchoprovocation challenge	7
A Comprehensive Review of Interstitial Lung Abnormalities	7
P5‐56: Predictive model for the development of critical coronavirus disease 2019 in Japan	6
P3‐1: Differential model of the deep convolutional neural network between sarcoidosis and lymphoma in 18F‐FDG‐PET/CT	6
P9‐39: Efficacy of vitamin d supplementation in children with asthma and vitamin D deficiency: A systematic review	6
P8‐69: Clinical study of chemotherapy with an immune checkpoint inhibitor combination chemotherapy in advanced small cell lung cancer	6
P10‐14: Long term follow‐up in pediatric OHS/OSA treated conservatively: Survival tips beyond home ventilation	6
Author Index	6
P7‐39: Evaluation of the effect of ICS containing triple therapy with LAMA/LABA in comparison with LAMA/LABA in COPD patients	6
P8‐170: A patient with ALK translocation‐positive lung adenocarcinoma in whom an EGFR mutation developed during the treatment with ALK inhibitors	6
P3‐2: Impact of air pollutant of polycyclic aromatic hydrocarbons (PAHS) on the yearly decline of pulmonary function in asthmatics sensitized to house dust mite (HDM)	6
O22‐5: Complete pulmonary function profiles of 267 post COVID patients with exertional dyspnea in Bangladesh	6
P2‐39: Assessment of inter‐lobe biological diversity in the lung by DNA methylation profiles in autopsy cases	6
P6‐23: Diagnostic utility of adenosine deaminase (ADA) activity in pleural fluid and pleural fluid lactate dehydrogenase/ADA ratio of tuberculous and non‐tuberculous pleural disease	6
P7‐33: The different significance between sedentary time and high‐intensity physical activities in patients with stable COPD	6
P6‐61: Association of serum antibodies against the Mycobacterium avium complex with hemoptysis	6
P8‐128: Phase II trial of pembrolizumab in poor performance status NSCLC patients with PD‐L1 ≥ 50%: OLCSG 1801	6
P2‐33: Blocking MMP‐12‐modulated epithelial‐mesenchymal transition by repurposing penfluridol retsrains lung adenocarcinoma metastasis via UPA/UPAR/TGF‐Β/AKT pathway	6
P1‐48: Metabolism of traditional Chinese medicine in the treatment of allergic rhinitis	6
Transformative radiology: Chest imaging is being re‐defined	5
Correction to APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)	5
P13‐3: Withdrawn	5
P8‐145: Successful immune checkpoint inhibition in an EGFR‐TKI‐refractory lung cancer with EGFR mutation and transformation	5
P16‐56: The effect of pulmonary macrophage transplantation on mice with bleomycin‐induced pulmonary fibrosis	5
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	5
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	5
Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis	5
Hansen's disease and the first patient disease Registry	5
Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy	5
	5
Letter from the United States: An update on the New York experience with COVID‐19	5
P8‐80: Bevacizumab suppresses epithelial‐to‐mesenchymal transition in EGFR‐mutant lung cancer	5
	5
Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases	5
Letter from Korea	5
The United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of the Parties, Dubai (COP28): Implications for lung disease	5
Predictors of psychological stress in silica‐exposed workers in the artificial stone benchtop industry	5
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	5
Issue Information	5
Author Index	5
P6‐2: To study the efficacy and safety of bedaquiline plus optimized background regimen and high dose moxifloxacin plus optimized background regimen in drug resistant pulmonary tuberculosis‐A prospect	5
P16‐67: Kinetic changes of serum KL‐6 levels predict disease progression in systemic sclerosis‐associated interstitial lung disease	5
P8‐95: Correlation of neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and carcinoembryonic antigen (CEA) with overall survival: Review of patients with non‐small cell carcinoma (NSC	5
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	5
Leading Women in Respiratory Clinical Sciences: Letter From Japan	5
Attenuation of exertional desaturation and preference for interval exercise compared to continuous exercise in people with interstitial lung disease	5
Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing	5
Issue Information	4
P5‐114: A young lady with bones in the lungs –A case of diffuse pulmonary fibro ossification complicated with fungal infection	4
P8‐84: S‐1 reduces myeloid‐derived suppressor cells in murine mesothelioma model and enhances the anti‐tumor activity of anti‐PD‐1 antibody	4
P12‐38: A young woman with bilateral primary spontaneous pneumothorax	4
O17‐4: Novel predictive biomarkers for mepolizumab treatment in patients with severe asthma	4
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial	4
P5‐85: Staged treatment of middle lobe lung gangrene using the vacuum‐assisted closure therapy in a patient with severe COVID‐19 pneumonia	4
P5‐111: SARS‐CoV‐2 PCR and antigen positivity continued for 3 months after treatment for severe COVID‐19: Case report	4
NT‐proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point‐of‐Care and Remote Monitoring	4
A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases	4
P7‐66: Clinical inertia in the management of COPD: A review of the literature	4
A visit to the gallery	4
P12‐3: Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions with ground‐glass opacity: A propensity score‐matched analysis	4
Issue Information	4
P2‐15: An HTERT/CDK4‐immortalized normal human bronchial epithelial cell line is highly resistant to mutant KRAS‐induced senescence	4
P16‐62: The prognostic factor of idiopathic interstitial pneumonias patients complicated with pneumothorax: A multicenter retrospective study	4
P1‐62: Elderly sarcoidosis in Japan	4
P5‐68: The use of an institutionalized respiratory protocol as a decision‐making tool improved outcomes among severe and critically‐ill COVID‐19 patients in Perpetual Succour Hospital	4
P8‐139: A case of pulmonary mucoepidermoid carcinoma treated with carboplatin, nab‐paclitaxel, and pembrolizumab	4
	4
O18‐4: Non‐invasive ventilation improves persistent tachycardia in a case of mitochondrial myopathy	4
P13‐1: Chest X‐ray findings of coronavirus‐19 disease in patients age 0 to 18 years old admitted at Chong Hua Hospital from March 2020 to February 2021	4
O2‐4: Prevalence, characteristics, risk factors and disease course of ulcerative colitis‐related pulmonary manifestations	4
P8‐30: Usefulness of pulmonary rehabilitation in non‐small cell lung cancer patients based on pulmonary function tests and muscle index analysis using computed tomography images	4
Tackling a Lifetime of Risk for OSA	4
Excess iron promotes emergence of foamy macrophages that overexpress ferritin in the lungs of silicosis patients	4
P6‐44: Case report of a newly diagnosed bacteriologically confirmed pulmonary tuberculosis in a patient with COVID‐19 critical infection	4
Correction to “APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)”	4
P6‐4: Endobronchial mass occurred during treatment of tuberculosis: Two cases	4
Issue Information	4
P9‐67: Adherence to inhaled corticosteroids in working‐age patients with asthma: A non‐interventional study with secondary use of data	4
P16‐53: Effectiveness of antifibrotic treatment for acute exacerbation of idiopathic pulmonary fibrosis	4
P8‐10: Minichromosome maintenance complex component (MCM) genes in lung adenocarcinoma: MCM‐family acts as a potential therapeutic target	4
P10‐20: Sleep and the usage of smart devices among Sri Lankan doctors	4
O4‐5: Combination of tryptase and IL‐33 in bronchoalveolar lavage fluid may predict the types of eosinophilic pneumonia and disease recurrence	4
P16‐97: Secondary organizing pneumonia following COVID‐19 infection	4
Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions	4
P15‐4: Pulmonary vasculopathy in pulmonary hypertension with interstitial lung disease: A morphometric study of autopsy cases	4
Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	4
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study‐2: Use of 2.5 mg alteplase as a starting intrapleural dose	4
	4
P12‐28: Bronchiolitis obliterans after bone marrow transplantation diagnosed by ultrathin bronchoscopy: A case report	4
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years	4
P1‐77: Long‐COVID syndrome associated with COVID‐19 pneumonia	4
Issue Information	4
P6‐18: Endobronchial ultrasound transbronchial aspiration biopsy (EBUS‐TBNA) in the diagnosis of mediastinal mass of unknown etiology: A case series	3